These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 25703303)
21. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs. Atkins JB; Chlan-Fourney J; Nye HE; Hiroi N; Carlezon WA; Nestler EJ Synapse; 1999 Aug; 33(2):118-28. PubMed ID: 10400890 [TBL] [Abstract][Full Text] [Related]
22. The Dopamine Allosteric Agent, PAOPA, Demonstrates Therapeutic Potential in the Phencyclidine NMDA Pre-clinical Rat Model of Schizophrenia. Daya RP; Bhandari J; Kooner SK; Ho J; Rowley CD; Bock NA; Farncombe T; Mishra RK Front Behav Neurosci; 2018; 12():302. PubMed ID: 30618660 [TBL] [Abstract][Full Text] [Related]
23. cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment. Chong VZ; Young LT; Mishra RK J Neurochem; 2002 Sep; 82(6):1533-9. PubMed ID: 12354301 [TBL] [Abstract][Full Text] [Related]
24. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379 [TBL] [Abstract][Full Text] [Related]
25. Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat. Linnér L; Wiker C; Wadenberg ML; Schalling M; Svensson TH Neuropsychopharmacology; 2002 Nov; 27(5):691-8. PubMed ID: 12431844 [TBL] [Abstract][Full Text] [Related]
26. Early stress and chronic methylphenidate cross-sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens. Jezierski G; Zehle S; Bock J; Braun K; Gruss M J Neurochem; 2007 Dec; 103(6):2234-44. PubMed ID: 17924950 [TBL] [Abstract][Full Text] [Related]
27. Long-term reciprocal changes in dopamine levels in prefrontal cortex versus nucleus accumbens in rats born by Caesarean section compared to vaginal birth. El-Khodor BF; Boksa P Exp Neurol; 1997 May; 145(1):118-29. PubMed ID: 9184115 [TBL] [Abstract][Full Text] [Related]
28. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core. Rouillon C; Abraini JH; David HN Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353 [TBL] [Abstract][Full Text] [Related]
29. Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: novel targets for antipsychotic drugs. Fuxe K; Borroto-Escuela DO; Tarakanov AO; Romero-Fernandez W; Ferraro L; Tanganelli S; Perez-Alea M; Di Palma M; Agnati LF Prog Brain Res; 2014; 211():113-39. PubMed ID: 24968778 [TBL] [Abstract][Full Text] [Related]
30. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum. Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244 [TBL] [Abstract][Full Text] [Related]
32. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Vawter MP; Thatcher L; Usen N; Hyde TM; Kleinman JE; Freed WJ Mol Psychiatry; 2002; 7(6):571-8. PubMed ID: 12140780 [TBL] [Abstract][Full Text] [Related]
33. Positive association between synapsin II and schizophrenia. Chen Q; He G; Wang XY; Chen QY; Liu XM; Gu ZZ; Liu J; Li KQ; Wang SJ; Zhu SM; Feng GY; He L Biol Psychiatry; 2004 Aug; 56(3):177-81. PubMed ID: 15271586 [TBL] [Abstract][Full Text] [Related]
34. The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex. Pira L; Mongeau R; Pani L Eur J Pharmacol; 2004 Nov; 504(1-2):61-4. PubMed ID: 15507222 [TBL] [Abstract][Full Text] [Related]
35. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol. Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005 [TBL] [Abstract][Full Text] [Related]
36. Characterization of dopamine D Szűcs E; Ducza E; Büki A; Kekesi G; Benyhe S; Horvath G Brain Res; 2020 Dec; 1748():147074. PubMed ID: 32858029 [TBL] [Abstract][Full Text] [Related]
37. Synapsin III: role in neuronal plasticity and disease. Porton B; Wetsel WC; Kao HT Semin Cell Dev Biol; 2011 Jun; 22(4):416-24. PubMed ID: 21827867 [TBL] [Abstract][Full Text] [Related]
38. Role of presynaptic phosphoprotein synapsin II in schizophrenia. Molinaro L; Hui P; Tan M; Mishra RK World J Psychiatry; 2015 Sep; 5(3):260-72. PubMed ID: 26425441 [TBL] [Abstract][Full Text] [Related]
39. In situ-gelling starch nanoparticle (SNP)/O-carboxymethyl chitosan (CMCh) nanoparticle network hydrogels for the intranasal delivery of an antipsychotic peptide. Majcher MJ; Babar A; Lofts A; Leung A; Li X; Abu-Hijleh F; Smeets NMB; Mishra RK; Hoare T J Control Release; 2021 Feb; 330():738-752. PubMed ID: 33383097 [TBL] [Abstract][Full Text] [Related]
40. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Mirnics K; Middleton FA; Marquez A; Lewis DA; Levitt P Neuron; 2000 Oct; 28(1):53-67. PubMed ID: 11086983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]